China Resources looks to take HK-listed Sihuan Pharma private at $3b valuation

State conglomerate China Resources is in early-stage talks with Sihuan Pharmaceutical’s chairman about jointly taking the Hong Kong-listed company private in a deal valuing it at nearly $3 billion, two people with knowledge of the matter said.